Serum neurofilament light chain as a prognostic marker of all-cause mortality in a national sample of US adults
- PMID: 38771439
- DOI: 10.1007/s10654-024-01131-7
Serum neurofilament light chain as a prognostic marker of all-cause mortality in a national sample of US adults
Abstract
Neurofilament light chain (NfL) is a neuron-specific structural protein released into the extracellular space, including body fluids, upon neuroaxonal damage. Despite evidence of a link in neurological disorders, few studies have examined the association of serum NfL with mortality in population-based studies. Data from the National Health and Nutrition Survey were utilized including 2,071 Non-Hispanic White, Non-Hispanic Black and Hispanic adult participants and adult participants of other ethnic groups (20-85 years) with serum NfL measurements who were followed for ≤ 6 years till 2019. We tested the association of serum NfL with mortality in the overall population and stratified by sex with the addition of potential interactive and mediating effects of cardio-metabolic risk factors and nutritional biomarkers. Elevated serum NfL levels (above median group) were associated with mortality risk compared to the below median NfL group in the overall sample (P = 0.010), with trends observed within each sex group (P < 0.10). When examining Loge NfL as a continuum, one standard deviation of Loge NfL was associated with an increased mortality risk (HR = 1.88, 95% CI 1.60-2.20, P < 0.001) in the reduced model adjusted for age, sex, race, and poverty income ratio; a finding only slightly attenuated with the adjustment of lifestyle and health-related factors. Four-way decomposition indicated that there was, among others, mediated interaction between NfL and HbA1c and a pure inconsistent mediation with 25(OH)D3 in predicting all-cause mortality, in models adjusted for all other covariates. Furthermore, urinary albumin-to-creatinine ratio interacted synergistically with NfL in relation to mortality risk both on the additive and multiplicative scales. These data indicate that elevated serum NfL levels were associated with all-cause mortality in a nationally representative sample of US adults.
Keywords: Aging; Biomarker; Mortality; Neurodegenerative disease; Neurofilament light chain; Population; Prognostic markers.
© 2024. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.
Similar articles
-
Plasma neurofilament light and its association with all-cause mortality risk among urban middle-aged men and women.BMC Med. 2022 Jun 13;20(1):218. doi: 10.1186/s12916-022-02425-x. BMC Med. 2022. PMID: 35692046 Free PMC article.
-
Association between urinary glyphosate levels and serum neurofilament light chain in a representative sample of US adults: NHANES 2013-2014.J Expo Sci Environ Epidemiol. 2024 Mar;34(2):287-293. doi: 10.1038/s41370-023-00594-2. Epub 2023 Sep 6. J Expo Sci Environ Epidemiol. 2024. PMID: 37674008
-
Serum neurofilament light and tau as prognostic markers for all-cause mortality in the elderly general population-an analysis from the MEMO study.BMC Med. 2021 Feb 15;19(1):38. doi: 10.1186/s12916-021-01915-8. BMC Med. 2021. PMID: 33583409 Free PMC article.
-
The potential of blood neurofilament light as a marker of neurodegeneration for Alzheimer's disease.Brain. 2024 Jan 4;147(1):12-25. doi: 10.1093/brain/awad267. Brain. 2024. PMID: 37540027 Review.
-
Neurofilament Light Chain as Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.Front Neurosci. 2021 Jun 21;15:679199. doi: 10.3389/fnins.2021.679199. eCollection 2021. Front Neurosci. 2021. PMID: 34234641 Free PMC article. Review.
References
-
- Raket LL, Kuhnel L, Schmidt E, Blennow K, Zetterberg H, Mattsson-Carlgren N. Utility of plasma neurofilament light and total tau for clinical trials in Alzheimer’s disease. Alzheimers Dement (Amst). 2020;12(1):e12099. https://doi.org/10.1002/dad2.12099 . - DOI - PubMed
-
- Hansson O, Janelidze S, Hall S, et al. Blood-based NfL: a biomarker for differential diagnosis of parkinsonian disorder. Neurology. 2017;88(10):930–7. https://doi.org/10.1212/WNL.0000000000003680 . - DOI - PubMed - PMC
-
- Preische O, Schultz SA, Apel A, et al. Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease. Nat Med. 2019;25(2):277–83. https://doi.org/10.1038/s41591-018-0304-3 . - DOI - PubMed - PMC
-
- de Wolf F, Ghanbari M, Licher S, et al. Plasma tau, neurofilament light chain and amyloid-beta levels and risk of dementia; a population-based cohort study. Brain. 2020;143(4):1220–32. https://doi.org/10.1093/brain/awaa054 . - DOI - PubMed - PMC
-
- Mattsson N, Cullen NC, Andreasson U, Zetterberg H, Blennow K. Association between longitudinal plasma neurofilament light and neurodegeneration in patients with Alzheimer disease. JAMA Neurol. 2019;76(7):791–9. https://doi.org/10.1001/jamaneurol.2019.0765 . - DOI - PubMed - PMC
Grants and funding
LinkOut - more resources
Full Text Sources